October 31st, 2022 / News Ubiquigent obtains exclusive license for UbiSite® technology to strengthen its specialist drug discovery services
July 5th, 2022 / News Ubiquigent appoints Professor Helen Walden and Professor John Davis to Scientific Advisory Board
December 14th, 2021 / News Ubiquigent celebrates milestone anniversary of DUBprofiler™ compound profiling platform